title: Prevalence and factors associated with lipodystrophy in AIDS patients.
abstract: BACKGROUND
  The published literature shows an increased occurrence of adverse events, such as human immunodeficiency virus (HIV)-associated lipodystrophy syndrome, that are associated with the continuous use of antiretroviral therapy. This study was performed to estimate the prevalence and factors associated with lipodystrophy in acquired immune deficiency syndrome (AIDS) patients.
  
  
  METHODS
  We conducted a cross-sectional study between October 2012 and February 2013. The sample consisted of patients with AIDS who attended the Outpatient Treatment Center for Infectious Diseases at Nereu Ramos Hospital, Florianópolis, State of Santa Catarina, Brazil. We collected information on demographics, lifestyle, HIV infection, and clinical aspects of the disease. Self-reported signs of lipodystrophy and body measurements were used for lipodystrophy diagnosis.
  
  
  RESULTS
  We studied 74 patients (mean age 44.3±9.2 years; 60.8% men). Among the patients, 45.9% were smokers, 31.1% consumed alcoholic beverages, and 55.4% were sedentary. The prevalence of lipodystrophy was 32.4%, and sedentary subjects had a higher prevalence of lipodystrophy compared with physically active individuals.
  
  
  CONCLUSIONS
  The prevalence of lipodystrophy was 32.4%. Physical activity was considered an independent protective factor against the onset of HIV-associated lipodystrophy.
authors.affiliation: Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, TubarãoSC, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, Tubarão, SC.
authors.forename: Lunara Basqueroto Della
authors.initials: LB
authors.lastname: Justina
authors.affiliation: Centro de Doenças Infecciosas, Hospital Nereu Ramos, FlorianópolisSC, Centro de Doenças Infecciosas, Hospital Nereu Ramos, Florianópolis, SC.
authors.forename: Magali Chaves
authors.initials: MC
authors.lastname: Luiz
authors.affiliation: Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, TubarãoSC, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, Tubarão, SC.
authors.forename: Rosemeri
authors.initials: R
authors.lastname: Maurici
authors.affiliation: Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, TubarãoSC, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Sul de Santa Catarina, Tubarão, SC.
authors.forename: Fabiana
authors.initials: F
authors.lastname: Schuelter-Trevisol
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D003430:Cross-Sectional Studies; D005260:Female; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced / Q000453:epidemiology*; D006801:Humans; D008019:Life Style; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012307:Risk Factors; D012959:Socioeconomic Factors; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents